Advent Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.9	1.77	3.97	1.07	4.31	2.69
Short-Term Investments	-	-	-	-	-	40
Cash & Short-Term Investments	0.9	1.77	3.97	1.07	4.31	42.69
Cash Growth	-75.14%	-55.41%	269.51%	-75.11%	-89.89%	-7.88%
Receivables	257.1	188.52	142.81	126.49	116.17	114.02
Inventory	79.91	66.17	67.24	79.75	81.33	75.41
Prepaid Expenses	-	-	0.05	0.05	0.05	0.04
Other Current Assets	28.19	28.15	28.01	29.83	32.72	29.81
Total Current Assets	366.1	284.61	242.08	237.2	234.59	261.98
Property, Plant & Equipment	1,614	1,648	1,615	1,551	1,409	1,258
Total Assets	1,981	1,932	1,857	1,788	1,644	1,520
Accounts Payable	9.95	10.08	9.64	20.6	10.42	8.92
Accrued Expenses	56.89	47.49	43.87	61.51	48.74	38.96
Short-Term Debt	61.24	58.67	60	54.99	43.27	36.83
Current Portion of Long-Term Debt	7.91	7.91	7.91	7.91	7.91	7.91
Current Portion of Leases	-	0.7	0.67	0.76	0.64	0.61
Current Income Taxes Payable	61.55	60.12	54.69	53.3	55.6	52.41
Other Current Liabilities	5.16	3.9	12.1	7.24	2.99	6.67
Total Current Liabilities	202.71	188.86	188.88	206.32	169.57	152.31
Long-Term Debt	6.71	7.43	7.43	7.43	11.02	14.56
Long-Term Leases	1.78	1.08	-	0.49	1.08	-
Long-Term Deferred Tax Liabilities	211.83	204.4	190.41	175.2	148.56	118.99
Other Long-Term Liabilities	-0	-	-	-	-	-
Total Liabilities	423.03	401.77	386.72	389.44	330.23	285.86
Common Stock	931.33	931.33	931.33	931.33	931.33	913.07
Retained Earnings	626.2	599.04	538.68	467.73	382.12	321.11
Shareholders' Equity	1,558	1,530	1,470	1,399	1,313	1,234
Total Liabilities & Equity	1,981	1,932	1,857	1,788	1,644	1,520
Total Debt	77.65	75.79	76.01	71.59	63.92	59.91
Net Cash (Debt)	-76.75	-74.03	-72.04	-70.52	-59.61	-17.22
Net Cash Per Share	-0.83	-0.79	-0.77	-0.76	-0.64	-0.18
Filing Date Shares Outstanding	88.04	93.13	93.13	93.13	93.13	93.13
Total Common Shares Outstanding	88.04	93.13	93.13	93.13	93.13	93.13
Working Capital	163.39	95.75	53.2	30.88	65.02	109.67
Book Value Per Share	17.69	16.43	15.78	15.02	14.10	13.25
Tangible Book Value	1,558	1,530	1,470	1,399	1,313	1,234
Tangible Book Value Per Share	17.69	16.43	15.78	15.02	14.10	13.25
Land	-	3.78	3.78	3.78	3.78	3.78
Buildings	-	1,245	1,245	1,245	1,123	925.16
Machinery	-	570.15	530.34	527.92	458.43	442.57
Construction In Progress	-	178.95	124.58	15.86	7.39	29.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.